-
Mashup Score: 0Unlocking Cancer Treatment: Nivolumab & Ipilimumab Explored - 8 month(s) ago
In the ever-evolving landscape of medical science, melanoma and Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) have remained two of the most formidable cancers to treat. Both of these cancers present unique challenges due to their aggressive nature and high recurrence rate. Yet, in the…
Source: oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Trends in the approval of cancer therapies by the FDA in the twenty-first century - Nature Reviews Drug Discovery - 9 month(s) ago
Cancer therapy has changed substantially since the beginning of the century, with advances including kinase inhibitors and immunotherapies resulting in substantial improvements in treatment outcomes. This Review summarizes trends in the approval of oncology therapeutic products by the FDA since 2000 and discusses the implications for the future of anticancer drug development.
Source: NatureCategories: Hem/Oncs, Latest HeadlinesTweet-
š„šØHot off the press, just published @NatRevDrugDisc, educational paper on: āTrends in the approval of #Cancer #Therapies by the FDA in the 21st century.ā In 22 years, @FDAOncology granted 573 #Oncology indication approvals for 206 oncology products. šš¼ https://t.co/TVLy84XRwg https://t.co/wmpY4ZmObH
-
-
Mashup Score: 0āSet the target, assess, adjustā: Drug choice for RA, PsA hinge on safety, efficacy, risks - 11 month(s) ago
DESTIN, Fla. ā Efficacy is just one of many factors that should be considered when choosing therapies for rheumatoid arthritis and psoriatic arthritis, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.
Source: www.healio.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 5Tumor cell malignancy: A complex trait built through reciprocal interactions between tumors and tissue-body system - 1 year(s) ago
Since the discovery of oncogenes and tumor suppressor genes in the late past century, cancer research has been overwhelmingly focused on the genetics ā¦
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
The increasing availability of biologics, both by expanding age indications and by development of new therapies, provides additional options to treat children and adolescents with severe asthma. However, the evidence for these biologics in these populations is limited compared with that for adult studies. As such, before initiation of therapy, possible alternative therapies that can also provide…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 1Vitiligo - 1 year(s) ago
Device TechnologyDrug WatchLegalLifestyleNP and PAPractice Management 2 Minute DrillAround the PracticeBetween The LinesCase Based Peer PerspectiveDermviewDermview: VitiligoEditorial Board NewsExpert InterviewsFrontline ForumInside the ClinicMedical World NewsPodcastsReadout360Recognize and ReferViewpointsWebinarsConference CoverageConference ListingImage IQInteractive ToolsJob…
Source: Dermatology TimesCategories: Dermatology, Latest HeadlinesTweet
-
Mashup Score: 0Cell & Gene Therapies - Friends of Cancer Research - 1 year(s) ago
Quick Links Sign Up for Updates 2022 CRS Publication Cell Therapies & the Patient Experience Designing the Future of Cell Therapies Cell and gene therapies are emerging therapies that represent a new treatment paradigm for many diseases including cancer.Ā Friends of Cancer Research (Friends)Ā supports alignment in the cell and gene therapy drug development space to ensureā¦
Source: Friends of Cancer ResearchCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Conversations in Epidermolysis Bullosa: Understanding the Patientās Unmet Needs and the Potential of Novel Therapies - 1 year(s) ago
Following a patient interview, Dr McGrath and colleagues discuss the enormous impact of epidermolysis bullosa and the therapies being developed for it.
Source: MedscapeCategories: Latest Headlines, PediatricsTweet
-
Mashup Score: 0A mixed methods study exploring requests for unproven COVID therapies such as ivermectin and healthcare distrust in the rural South - 1 year(s) ago
The COVID-19 pandemic has led to contentious discourse regarding unproven COVID-19 therapies (UCTs),(e.g. ivermectin). Despite recommendations againstā¦
Source: www.sciencedirect.comCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0
Current antifibrotic agents are not curative for idiopathic pulmonary fibrosis (IPF). Moreover, existing preclinical models do not fully replicate the human …
Source: YouTubeCategories: Latest Headlines, PulmonologyTweet
Targeted #therapies like #nivolumab & #ipilimumab focus on specific genes in #cancer cells, offering precision over traditional treatments. Dive deeper with our article & an interview with Dr. Kevin Harrington from #ASCO23. @kevhar6763 @royalmarsdenNHS https://t.co/igPBhfyv7Z